When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Thinly traded nano cap Millendo Therapeutics (NASDAQ:MLND) slumps 69% premarket on increased volume in reaction to unsuccessful results from a Phase 2b clinical trial evaluating lead drug livoletide in patients with Prader-Willi syndrome (PWS), an inherited disorder characterized by obesity and type 2 diabetes due to insatiable hunger.
More news on: Millendo Therapeutics, Inc., Healthcare stocks news, Stocks on the move,